Trial Profile
Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 23 Jul 2018 Status changed from active, no longer recruiting to completed.
- 05 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 18 Jan 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2018.